MYRIAMED Trademark

Trademark Overview


On Thursday, April 7, 2022, a trademark application was filed for MYRIAMED with the United States Patent and Trademark Office. The USPTO has given the MYRIAMED trademark a serial number of 79350987. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by myriamed GmbH. The MYRIAMED trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Scientific research and laboratory apparatus for drug screening or potency assays; cell culture apparatus for laboratory use, in particular cell culture plates and tissue culture plates for the generation and/or cultivation of engineered tissue

Pharmaceutical and veterinary preparations, in particular cells and tissues for treatment of cardiac diseases, degenerative muscular diseases, fibrotic diseases, neurodegenerative diseases, connective tissue diseases or disorders with impaired scaring and wound healing; pharmaceutical preparations for the renewal and regeneration of organs; pharmaceutical preparations for use in cellular therapy; biological tissue derived from stem cells for medical purposes; tissue-regenerative pharmaceutical preparations

Chemicals for use in industry and science, in particular reagents for cultivation of cells and tissue; cells for research or for scientific purposes, namely, cells, in particular genetically modified cells, human cells and cells derived from induced pluripotent stem cells, in particular cardiomyocytes derived from human induced pluripotent stem cells, skeletal cells derived from human induced pluripotent stem cells, stroma cells derived from human induced pluripotent stem cells, and neuronal cells derived from human induced pluripotent stem cells; biological tissues, other than for medical or veterinary purposes, namely, tissues in particular engineered tissues, in particular tissue comprising cells derived from induced pluripotent stem cells and macroscale muscle tissue, in particular human heart muscle constructed from cardiomyocytes derived from human induced pluripotent stem cells, human skeletal muscle constructed from skeletal cells derived from human induced pluripotent stem cel...

Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues; drug discovery services, in particular drug discovery services based on tissue engineered organ platforms; scientific and technological services and research in the field of regenerative medicine; cell culture services for scientific and research purposes, for others
myriamed

General Information


Serial Number79350987
Word MarkMYRIAMED
Filing DateThursday, April 7, 2022
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7376414
Registration DateTuesday, May 7, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesScientific research and laboratory apparatus for drug screening or potency assays; cell culture apparatus for laboratory use, in particular cell culture plates and tissue culture plates for the generation and/or cultivation of engineered tissue
Goods and ServicesPharmaceutical and veterinary preparations, in particular cells and tissues for treatment of cardiac diseases, degenerative muscular diseases, fibrotic diseases, neurodegenerative diseases, connective tissue diseases or disorders with impaired scaring and wound healing; pharmaceutical preparations for the renewal and regeneration of organs; pharmaceutical preparations for use in cellular therapy; biological tissue derived from stem cells for medical purposes; tissue-regenerative pharmaceutical preparations
Goods and ServicesChemicals for use in industry and science, in particular reagents for cultivation of cells and tissue; cells for research or for scientific purposes, namely, cells, in particular genetically modified cells, human cells and cells derived from induced pluripotent stem cells, in particular cardiomyocytes derived from human induced pluripotent stem cells, skeletal cells derived from human induced pluripotent stem cells, stroma cells derived from human induced pluripotent stem cells, and neuronal cells derived from human induced pluripotent stem cells; biological tissues, other than for medical or veterinary purposes, namely, tissues in particular engineered tissues, in particular tissue comprising cells derived from induced pluripotent stem cells and macroscale muscle tissue, in particular human heart muscle constructed from cardiomyocytes derived from human induced pluripotent stem cells, human skeletal muscle constructed from skeletal cells derived from human induced pluripotent stem cells, human fibrotic tissue constructed from stroma cells derived from human induced pluripotent stem cells, connective tissue constructed from connective tissue cells derived from human induced pluripotent stem cells, brain tissue derived from human induced pluripotent stem cells, and neuronal organoids; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes, namely, disease models based on engineered tissue or engineered cells
Goods and ServicesScientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues; drug discovery services, in particular drug discovery services based on tissue engineered organ platforms; scientific and technological services and research in the field of regenerative medicine; cell culture services for scientific and research purposes, for others

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Namemyriamed GmbH
Party Type30 - Original Registrant
Legal Entity Type28 - NOT AVAILABLE
AddressDE

Party Namemyriamed GmbH
Party Type20 - Owner at Publication
Legal Entity Type28 - NOT AVAILABLE
AddressDE

Party Namemyriamed GmbH
Party Type10 - Original Applicant
Legal Entity Type28 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Thursday, September 29, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 4, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, January 25, 2023ASSIGNED TO EXAMINER
Saturday, February 11, 2023NON-FINAL ACTION WRITTEN
Sunday, February 12, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 31, 2023REFUSAL PROCESSED BY MPU
Friday, March 31, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 25, 2023REFUSAL PROCESSED BY IB
Monday, September 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, February 26, 2024NOTIFICATION PROCESSED BY IB
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, March 25, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 7, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 30, 2024FINAL DISPOSITION PROCESSED
Thursday, October 31, 2024FINAL DISPOSITION NOTICE SENT TO IB
Saturday, November 23, 2024FINAL DECISION TRANSACTION PROCESSED BY IB